PT89267A - Metodo para a inibicao do virus da imunodeficiencia humana utilizando derivadod de pirrolidina ou piridina - Google Patents

Metodo para a inibicao do virus da imunodeficiencia humana utilizando derivadod de pirrolidina ou piridina

Info

Publication number
PT89267A
PT89267A PT198889267A PT8926788A PT89267A PT 89267 A PT89267 A PT 89267A PT 198889267 A PT198889267 A PT 198889267A PT 8926788 A PT8926788 A PT 8926788A PT 89267 A PT89267 A PT 89267A
Authority
PT
Portugal
Prior art keywords
dideoxy
imino
methyl
ribitol
immunodeficiency virus
Prior art date
Application number
PT198889267A
Other languages
English (en)
Other versions
PT89267B (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PT89267A publication Critical patent/PT89267A/pt
Publication of PT89267B publication Critical patent/PT89267B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86Oxygen atoms
    • C07D211/88Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT89267A 1987-12-21 1988-12-20 Metodo para a inibicao do virus da imunodeficiencia humana utilizando derivadod de pirrolidina ou piridina PT89267B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13621987A 1987-12-21 1987-12-21
US07/249,144 US4999360A (en) 1987-12-21 1988-09-26 Method of inhibiting virus

Publications (2)

Publication Number Publication Date
PT89267A true PT89267A (pt) 1989-12-29
PT89267B PT89267B (pt) 1993-12-31

Family

ID=26834131

Family Applications (1)

Application Number Title Priority Date Filing Date
PT89267A PT89267B (pt) 1987-12-21 1988-12-20 Metodo para a inibicao do virus da imunodeficiencia humana utilizando derivadod de pirrolidina ou piridina

Country Status (16)

Country Link
US (1) US4999360A (pt)
EP (1) EP0322395B1 (pt)
JP (1) JP2538014B2 (pt)
KR (1) KR910009994B1 (pt)
AT (1) ATE87206T1 (pt)
AU (1) AU607834B2 (pt)
CA (1) CA1316929C (pt)
DE (1) DE3879653T2 (pt)
DK (1) DK175113B1 (pt)
FI (1) FI93210C (pt)
IE (1) IE63095B1 (pt)
IL (1) IL88742A (pt)
NO (1) NO172340C (pt)
NZ (1) NZ227410A (pt)
OA (1) OA08937A (pt)
PT (1) PT89267B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68925940T2 (de) * 1988-11-03 1996-10-24 Searle & Co Dideoxy-L-arabinitol Derivate als Antivirus-Verbindungen
US4894388A (en) * 1988-12-22 1990-01-16 Monsanto Company Glycosidase inhibitors and use thereof
US5100797A (en) * 1989-06-27 1992-03-31 Monsanto Company Fucosidase inhibitors
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
IT1239950B (it) * 1990-03-28 1993-11-27 Zambon Spa Processo per la preparazione di composti con attivita' analgesica centrale
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5290948A (en) * 1990-09-17 1994-03-01 Mcneilab, Inc. Process for producing polyhydroxylated piperidines and pyrrolidines and compounds thereof
GB9026271D0 (en) * 1990-12-03 1991-01-16 Alphey Thomas J W Control of parasitic nematodes(a)
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5451679A (en) * 1994-03-08 1995-09-19 G. D. Searle & Co. 2-chloro and 2-bromo derivatives of 1,5-iminosugars
CZ120398A3 (cs) * 1995-09-08 1998-12-16 Novo Nordisk A/S Použití 2-alkylpyrrolidinových derivátů pro přípravu léčiva pro léčbu diabetu, 2-alkylpyrrolidiné deriváty
CN102399228B (zh) * 2010-09-08 2013-10-16 中国科学院成都生物研究所 N-烷基多羟基哌啶衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3507019A1 (de) * 1985-02-28 1986-08-28 Bayer Ag, 5090 Leverkusen Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung
EP0252962B1 (en) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulating retroviral replication, infection, and pathogenesis

Also Published As

Publication number Publication date
NO885655L (no) 1989-06-22
FI885880A0 (fi) 1988-12-20
DK708188D0 (da) 1988-12-20
FI93210C (fi) 1995-03-10
CA1316929C (en) 1993-04-27
FI93210B (fi) 1994-11-30
KR910009994B1 (ko) 1991-12-10
IL88742A0 (en) 1989-07-31
JP2538014B2 (ja) 1996-09-25
IE883794L (en) 1989-06-21
JPH01230517A (ja) 1989-09-14
EP0322395B1 (en) 1993-03-24
FI885880A (fi) 1989-06-22
NO172340C (no) 1993-07-07
NZ227410A (en) 1991-06-25
DE3879653T2 (de) 1993-10-14
OA08937A (fr) 1989-10-31
IE63095B1 (en) 1995-03-22
PT89267B (pt) 1993-12-31
AU2706888A (en) 1989-06-22
KR890009389A (ko) 1989-08-01
DE3879653D1 (de) 1993-04-29
US4999360A (en) 1991-03-12
AU607834B2 (en) 1991-03-14
EP0322395A1 (en) 1989-06-28
DK708188A (da) 1989-06-22
DK175113B1 (da) 2004-06-07
NO172340B (no) 1993-03-29
NO885655D0 (no) 1988-12-20
IL88742A (en) 1993-08-18
ATE87206T1 (de) 1993-04-15

Similar Documents

Publication Publication Date Title
DK73193D0 (da) Substituerede 1-(4-piperidinyl)-2-(phenylethylpyridinyl)-methanoner
DE69014393T2 (de) Heterocyclische N-Oxid-Derivate substituierter Benzo[5,6]cycloheptapyridine, Zusammensetzungen und Methoden der Verwendung.
PT89267A (pt) Metodo para a inibicao do virus da imunodeficiencia humana utilizando derivadod de pirrolidina ou piridina
HU911771D0 (en) Process for producing substituted and heterocyclic phthalides
NO931867L (no) Aminokinolonderivater substituert med arylgrupper og aromatiske heteocykliske grupper, samt middel mot HIV
DK0807633T3 (da) Hidtil ukendte 2,3-disubstituerede-(5,6)-heteroarylkondenserede pyrimidin-4-oner
ATE142496T1 (de) Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes
ATE123024T1 (de) 4-aminopyridinderivate.
DE69231422T2 (de) Pyridoncarbonsäurederivate
DK0388298T3 (da) Azetidinylsubstituerede derivater af pyridoncarboxylsyrer, deres fremstilling og anvendelse som lægemidler
DK0556152T3 (da) Pyridiniumderivater og deres anvendelse til bestemmelse af bindevævssygdomme hos mennesker og dyr
SE8301072L (sv) 1,4-dihydropyridinderivat, deras framstellning och farmaceutiska beredningar innehallande dessa

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19930621

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20041221

NF3A Restitutio in integrum

Free format text: RESTITUTIO IN INTEGRUM

Effective date: 20050412